Acute Myeloid Leukemias Clinical Trials in Sutton
2 recruitingSutton, United Kingdom
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Acute Myeloid Leukemias
Syndax Pharmaceuticals468 enrolled24 locationsNCT07211958
Recruiting
Phase 1
A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias
Acute Myeloid Leukemias
Syndax Pharmaceuticals76 enrolled46 locationsNCT06226571